Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.

The Serotonin Syndrome

Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821 · see citing works

Dangerous properties of industrial materials

Sax, N. I., & Lewis, R. J. (1969) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(69)80328-7 · Cited by 1,141 · see citing works

Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca

McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398 · see citing works

The error of determination of toxicity

Trevan, J. W. (1927) · Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character · doi:10.1098/rspb.1927.0030 · Cited by 392 · see citing works

Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338 · see citing works

Comparison of acute lethal toxicity of commonly abused psychoactive substances

Gable, R. S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00744.x · Cited by 322 · see citing works

Pharmacokinetics of Hoasca alkaloids in healthy humans

Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. O., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 318 · see citing works

Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers

Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · see citing works

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020009001 · Cited by 291 · see citing works

Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors

Herraiz, T., & Chaparro, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.033 · Cited by 258 · see citing works

Sax's dangerous properties of industrial materials

(1993) · Choice Reviews Online · doi:10.5860/choice.30-2435 · Cited by 210 · see citing works

TiHKAL: The Continuation

Shulgin, A. T., & Shulgin, A. (1997) · Cited by 198 · see citing works

“Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation

Rivier, L., & Lindgren, J. (1972) · Economic Botany · doi:10.1007/bf02860772 · Cited by 174 · see citing works

Cardiovascular effects of caffeine in men and women

Hartley, T. R., Lovallo, W. R., & Whitsett, T. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.057 · Cited by 168 · see citing works

Toxicity of Peganum harmala: Review and a Case Report

Mahmoudian, M., Jalilpour, H., & Salehian, P. (2002) · TSpace (University of Toronto) · Cited by 156 · see citing works

Plants of the Gods: Origins of Hallucinogenic Use

Brenan, J. P. M., Schultes, R. E., & Hofmann, A. (1980) · Kew Bulletin · doi:10.2307/4110029 · Cited by 154 · see citing works

A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation.

Sklerov, J., Levine, B., Moore, K. A., King, T., & Fowler, D. (2005) · Journal of Analytical Toxicology · doi:10.1093/jat/29.8.838 · Cited by 144 · see citing works

Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine

Ott, J. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471741 · Cited by 140 · see citing works

Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial

Lester, S. J., Baggott, M. J., Welm, S., Schiller, N. B., Jones, R. T., Foster, E., & Mendelson, J. E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00012 · Cited by 138 · see citing works

Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions

Callaway, J. C., & Grob, C. S. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399712 · Cited by 137 · see citing works

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Strassman, R. J., Qualls, C. R., & Berg, L. M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00200-6 · Cited by 130 · see citing works

The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine

Gillin, J. C., Kaplan, J., Stillman, R. C., & Wyatt, R. J. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.203 · Cited by 123 · see citing works

‘Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil’

Barbosa, P. C. R., Giglio, J. S., & Dalgalarrondo, P. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399801 · Cited by 120 · see citing works

Monoamine Oxidase Inhibitor Poisoning Resulting from Internet Misinformation on Illicit Substances

Brush, D. E., Bird, S. B., & Boyer, E. W. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120030949 · Cited by 120 · see citing works

A foxy intoxication

Wilson, J. M., McGeorge, F., Smolinske, S. C., et al. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2004.04.017 · Cited by 119 · see citing works

Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine

Jacob, M., & Presti, D. E. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.11.005 · Cited by 118 · see citing works

Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.

Azorlosa, J. L., Heishman, S. J., Stitzer, M. L., & Mahaffey, J. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10949-x · Cited by 117 · see citing works

Acute hemodynamic effects of ethanol on normal human volunteers

Riff, D. P., Jain, A. C., & Doyle, J. T. (1969) · American Heart Journal · doi:10.1016/0002-8703(69)90510-9 · Cited by 115 · see citing works

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

Fantegrossi, W. E., Woods, J. H., & Winger, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200403000-00007 · Cited by 101 · see citing works

Comparison of Blood-Ethanol Concentration in Deaths Attributed to Acute Alcohol Poisoning and Chronic Alcoholism

Jones, A. W., & Holmgren, P. (2003) · Journal of Forensic Sciences · doi:10.1520/jfs2002420 · Cited by 92 · see citing works

Phytochemical Analyses ofBanisteriopsis CaapiandPsychotria Viridis

Callaway, J. C., Brito, G. S., & Neves, E. S. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399795 · Cited by 92 · see citing works

The Internet and Psychoactive Substance Use Among Innovative Drug Users

Boyer, E. W., Shannon, M. W., & Hibberd, P. L. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1199 · Cited by 87 · see citing works

Acute Toxic Effects of Club Drugs

Gable, R. S. (2004) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2004.10400031 · Cited by 81 · see citing works

Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases

Klock, J., Boerner, U., & Becker, C. E. (1975) · Clinical Toxicology · doi:10.3109/15563657508988063 · Cited by 78 · see citing works

The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM‐IV dependence criteria

Morgenstern, J., Langenbucher, J. W., & Labouvie, E. W. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb02787.x · Cited by 78 · see citing works

Various Alkaloid Profiles in Decoctions of Banisteriopsis Caapi

Callaway, J. C. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399796 · Cited by 77 · see citing works

Foxy, a Designer Tryptamine Hallucinogen*

Meatherall, R. C., & Sharma, P. K. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.5.313 · Cited by 77 · see citing works

Cardiovascular Actions of Three Harmala Alkaloids: Harmine, Harmaline, and Harmalol

Aarons, D. H., Rossi, G., & Orzechowski, R. F. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660910 · Cited by 69 · see citing works

Sociopsychotherapeutic Functions of Ayahuasca Healing in Amazonia

Andritzky, W. (1989) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1989.10472145 · Cited by 59 · see citing works

Bringing Ayahuasca to the Clinical Research Laboratory

Jordi Riba, A., & Barbanoj, M. J. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399804 · Cited by 58 · see citing works

Experimental toxicity of Peganum harmala seeds.

Lamchouri, F., Settaf, A., Cherrah, Y., et al. (2002) · PubMed · Cited by 54 · see citing works

Scopolamine Poisoning From Homemade ‘Moon Flower’ Wine

Smith, E. A., Meloan, C. E., Pickell, J. A., & Oehme, F. W. (1991) · Journal of Analytical Toxicology · doi:10.1093/jat/15.4.216 · Cited by 53 · see citing works

Plants of the Gods: Origins of Hallucinogenic Use

Liskow, B. I. (1980) · JAMA · doi:10.1001/jama.1980.03310170076041 · Cited by 51 · see citing works

Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications

Hyde, C. E., Glancy, G., Omerod, P., Hall, D., & Taylor, G. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.132.6.602 · Cited by 46 · see citing works

Acute Toxicology Testing: Perspectives and Horizons

Gad, S. C., & Chengelis, C. P. (1988) · Medical Entomology and Zoology · Cited by 43 · see citing works

Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects

Foltin, R. W., & Haney, M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.02.018 · Cited by 43 · see citing works

Failure of N,N-dimethyltryptamine to evoke tolerance in cats.

Gillin, J. C., Cannon, E. A., Magyar, R. L., Schwartz, M., & Wyatt, R. J. (1973) · PubMed · Cited by 43 · see citing works

Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS

T. Forsström, J. T. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101753218319 · Cited by 41 · see citing works

Psychoactive sacramentals: Essays on entheogens and religion.

Roberts, T. B. (2001) · Cited by 41 · see citing works

Blood dimethyltryptamine concentrations in psychotic disorders.

Lipinski, J. F., MANDEL, L. R., Hs, A., Heuvel, W. J. A. V., & Rw, W. (1974) · PubMed · Cited by 39 · see citing works

The effects of N,N-dimethyltryptamine on operant behavior in squirrel monkeys

Cole, J. M., & Pieper, W. A. (1973) · Psychopharmacology · doi:10.1007/bf00422642 · Cited by 34 · see citing works

Collective poisoning with hallucinogenous herbal tea

Balı́ková, M. (2002) · Forensic Science International · doi:10.1016/s0379-0738(02)00162-7 · Cited by 33 · see citing works

Altered consciousness states and endogenous psychoses: a common molecular pathway?

Ciprian‐Ollivier, J., & Cetkovich, M. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00116-3 · Cited by 33 · see citing works

Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.

Kovacic, B., & Domino, E. F. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30534-3 · Cited by 33 · see citing works

A Longitudinal Study of Urinary Excretion of N,N,-Dimethyltryptamine in Psychotic Patients

Checkley, S. A., Murray, R. M., Oon, M. C. H., Rodnight, R., & Birley, J. L. T. (1980) · The British Journal of Psychiatry · doi:10.1192/bjp.137.3.236 · Cited by 30 · see citing works

Human pharmacology of ayahuasca

Serrano, J. R. (2003) · TDX (Tesis Doctorals en Xarxa) · Cited by 25 · see citing works

Native use and occurence of N,N-Dimethyltryptamine in the leaves of Banisteriopsis rusbyana.

Ah, M., Pinkley, H. V., & Mf, D. (1969) · PubMed · Cited by 24 · see citing works

5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.

Gillin, J. C., Tinklenberg, J. R., Stoff, D. M., Stillman, R. C., Shortlidge, J. S., & Wyatt, R. J. (1976) · PubMed · Cited by 23 · see citing works

Interview with Guillermo Arrévalo, a Shipibo Urban Shaman, by Roger Rumrrill

de Ríos, M. D. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399802 · Cited by 20 · see citing works

Risk Assessment and Preventive Hazard Minimization

Neubert, D. (1999) · Elsevier eBooks · doi:10.1016/b978-012473270-4/50110-3 · Cited by 12 · see citing works

Cult-Hoasca: A Model for Schizophrenia.

Pomilio, A. B., Vitale, A. A., & Ciprian‐Ollivier, J. (2003) · Cited by 6 · see citing works

Acute toxicology testing

(2013) · CRC Press eBooks · doi:10.1201/b15319-7 · Cited by 5 · see citing works

Caffeine Consciousness

Primack, W. A. (2004) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.158.11.1092-a · Cited by 1 · see citing works

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343 · see citing works

Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada

Thomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990003 · Cited by 330 · see citing works

The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization

Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works

Assessment of addiction severity among ritual users of ayahuasca.

Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227 · see citing works

Clinical applications of hallucinogens: a review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201 · see citing works

Serotonin toxicity of serotonergic psychedelics

Malcolm, B., & Thomas, K. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05876-x · Cited by 138 · see citing works

Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca

Winkelman, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107120011 · Cited by 126 · see citing works

The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652578 · Cited by 125 · see citing works

Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey

Bouso, J. C., Andión, Ó., Sarris, J. J., Scheidegger, M., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000438 · Cited by 118 · see citing works

Toxicokinetics and Toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact

Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117 · see citing works

Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks

Kavenská, V., & Simonová, H. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1094590 · Cited by 108 · see citing works

Experiences of encounters with Ayahuasca–“the vine of the soul”

Kjellgren, A., Eriksson, A., & Norlander, T. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399767 · Cited by 97 · see citing works

Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice.

Oliveira-Lima, A. J., Santos, R., Hollais, A. W., Gerardi-Junior, C. A., Baldaia, M. A., Wuo-Silva, R., Yokoyama, T. S., Costa, J. L., Malpezzi-Marinho, E. L. A., Ribeiro-Barbosa, P. C., et al. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.01.032 · Cited by 91 · see citing works

Chemical composition of traditional and analog Ayahuasca

Kaasik, H., Souza, R. C. Z., Zandonadi, F. S., Tófoli, L. F., & Sussulini, A. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1815911 · Cited by 59 · see citing works

Psychedelic drug use in healthy individuals: a review of benefits, costs, and implications for drug policy

Elsey, J. W. B. (2017) · Drug Science Policy and Law · doi:10.1177/2050324517723232 · Cited by 57 · see citing works

Potential use of ayahuasca in grief therapy

González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2019) · OMEGA - Journal of Death and Dying · doi:10.1177/0030222817710879 · Cited by 44 · see citing works

Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands

Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24 · see citing works

2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug

Snyder, S. H., Faillace, L. A., & Hollister, L. E. (1967) · Science · doi:10.1126/science.158.3801.669 · Cited by 146 · see citing works

Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

Simão, A. Y., Gonçalves, J., Duarte, A. P., Barroso, M., Cristóvão, A. C., & Gallardo, E. (2019) · Medicines · doi:10.3390/medicines6040106 · Cited by 40 · see citing works

Hallucinogens and Psychedelics

Jenkins, A. J., & Gates, M. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-42917-1_26 · Cited by 5 · see citing works

Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples

Silveira, G. D. O., SANTOS, R. G. D., Lourenço, F. R., Rossi, G. N., Hallak, J. E. C., & Yonamine, M. (2020) · Molecules · doi:10.3390/molecules25092072 · Cited by 37 · see citing works

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment

Brierley, D. I., & Davidson, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.001 · Cited by 137 · see citing works